Clinical trials
Active, not recruiting Phase 1 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 5 |
| Memorial Sloan Kettering Cancer Center | 5 |
| AbbVie | 4 |
| Baylor College of Medicine | 2 |
| Genentech, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Massachusetts General Hospital | 2 |
| Mayo Clinic | 2 |
| Pfizer | 2 |
| Poseida Therapeutics, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 55 |
| Recurrence | 11 |
| Neoplasms, Plasma Cell | 4 |
| Leukemia | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Neoplasms | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia, Plasma Cell | 2 |
| Lymphoma | 2 |
| Myelodysplastic Syndromes | 2 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.